Table 3

Adjusted HRs with 95% CIs for the risk of all-cause and cardiovascular mortality associated with statin use stratified by sex

Whole population (n=17 262)Women (n=8981)Men (n=8281)
All-cause mortality (nevent=1035)
No statin (ref)111
Statin0.76 (0.71 to 0.82)0.66 (0.58 to 0.74)0.89 (0.81 to 0.96)
Cardiovascular mortality (nevent=270)
No statin (ref)111
Statin0.72 (0.61 to 0.83)0.55 (0.39 to 0.71)0.93 (0.77 to 1.08)